🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

3 recruiting trials

for Dravet Syndrome (DS)

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome NCT07675746EARLY Phase 11 site📍 Guangzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: RC001 injection-Dose Escalation Cohort, RC001 injection-Fixed Dose Cohort Assessment of Safety of the Use of Fenfluramine in Children With Dravet Syndrome Under 24 Months of Age NCT06598449Phase 41 site📍 Aurora University of Colorado, Denver · Tests: fenfluramine The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project NCT07112365Phase 41 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy